PSILOCYBIN
Clinical trials for PSILOCYBIN explained in plain language.
Never miss a new study
Get alerted when new PSILOCYBIN trials appear
Sign up with your email to follow new studies for PSILOCYBIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Psilocybin trial aims to shield cancer patients from chemo nerve pain
Prevention Not yet recruitingThis Phase 2 trial tests whether psilocybin, a psychedelic compound, can prevent or lessen chemotherapy-induced peripheral neuropathy (nerve damage) in people with breast, colorectal, or head and neck cancer. About 83 participants will receive either psilocybin, a low-dose placeb…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Magic mushroom therapy for depression? new trial tests psilocybin and CBT in groups
Symptom relief Not yet recruitingThis phase 2 trial will test whether giving psilocybin (the active ingredient in magic mushrooms) along with group cognitive behavioral therapy is acceptable and feasible for people with major depression. Thirty adults with current depressive symptoms will receive two doses of ps…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Magic mushroom compound tested for back pain relief in new yale study
Symptom relief Not yet recruitingThis study tests whether a single dose of psilocybin can help people with chronic low back pain become more aware of their body, which may lead to better pain relief and improved results from physical therapy. About 45 adults aged 18-65 with long-lasting back pain will receive ps…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Magic mushroom compound studied in healthy volunteers for brain and body effects
Knowledge-focused Not yet recruitingThis study gives 50 healthy adults a one-time dose of psilocybin (the active ingredient in magic mushrooms) or a placebo to measure changes in brain waves, blood chemicals, and empathy. Participants must have never used psychedelics before. The goal is to understand the biologica…
Matched conditions: PSILOCYBIN
Phase: PHASE1 • Sponsor: Gabriella Gobbi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC